Pfizer starts Phase 2/3 clinical study to evaluate safety, efficacy of COVID-19 oral treatment in pediatric population
Mar 09, 2022
Washington [US], March 9 : Pharmaceutical company Pfizer on Tuesday (local time) stated that it has started the Phase 2/3 clinical study to evaluate...